Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/787
Title: | ADding negative pRESSure to improve healING (the DRESSING trial): a RCT protocol | Authors: | Whitty, Jennifer A. Ellwood, David Stapleton, Helen Chaboyer, Wendy Mahomed, Kassam Gillespie, Brigid M. Webster, Joan Cullum, Nicky Thalib, Lukman |
Issue Date: | 2016 | Source: | 02/0110/18/received |11/19/revised |12/23/accepted | 6, (2), 2016, p. e010287 | Pages: | e010287 | Journal: | BMJ Open | Abstract: | INTRODUCTION: Obese women are more likely to develop a surgical site infection (SSI) following caesarean section (CS) than non-obese women. Negative pressure wound therapy (NPWT) is increasingly being used to reduce SSI with limited evidence for its effectiveness. OBJECTIVES: To determine the clinical and cost-effectiveness of using NPWT in obese women having elective and semiurgent CS. METHODS AND ANALYSIS: A multisite, superiority parallel pragmatic randomised controlled trial with an economic evaluation. Women with a body mass index (BMI) of ≥30, booked for elective and semiurgent CS at 4 Australian acute care hospitals will be targeted. A total of 2090 women will be enrolled. A centralised randomisation service will be used with participants block randomised to either NPWT or standard surgical dressings in a 1:1 ratio, stratified by hospital. The primary outcome is SSI; secondary outcomes include type of SSI, length of stay, readmission, wound complications and health-related quality of life. Economic outcomes include direct healthcare costs and cost-effectiveness, which will be evaluated using incremental cost per quality-adjusted life year gained. Data will be collected at baseline, and participants followed up on the second postoperative day and weekly from the day of surgery for 4 weeks. Outcome assessors will be masked to allocation. The primary statistical analysis will be based on intention-to-treat. ETHICS AND DISSEMINATION: Ethics approval has been obtained from the ethics committees of the participating hospitals and universities. The findings of the trial will be disseminated through peer-reviewed journals, national and international conference presentations. TRIAL REGISTRATION NUMBER: ACTRN12615000286549; Pre-results.bmjopen-2015-010287[PII]26832435[pmid] | DOI: | 10.1136/bmjopen-2015-010287 | Resources: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746446/ | Type: | Article |
Appears in Sites: | West Moreton HHS Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.